PAVmed (PAVM) Shareholder's Equity Growth (5y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 117.92% |
| Sep 30, 2025 | 33.26% |
| Jun 30, 2025 | 33.24% |
| Mar 31, 2025 | 34.48% |
| Dec 31, 2024 | 11.66% |
| Jun 30, 2024 | -58.24% |
| Mar 31, 2024 | -29.41% |
| Dec 31, 2023 | -57.53% |
| Sep 30, 2023 | -45.14% |
| Jun 30, 2023 | -16.30% |
| Mar 31, 2023 | 112.76% |
| Dec 31, 2022 | 42.32% |
| Sep 30, 2022 | 46.85% |
| Jun 30, 2022 | 59.12% |
| Mar 31, 2022 | 76.24% |
| Dec 31, 2021 | 201.93% |
| Sep 30, 2021 | 98.49% |
| Jun 30, 2021 | 72.54% |
| Dec 31, 2020 | -22.39% |